November 30, 2017 09:14 AM EST
Financing

An­ti-ag­ing start­up ResTOR­bio gets $40M to fu­el Phase IIb study

Brittany Meiling

ResTOR­bio, a new com­pa­ny de­vel­op­ing tech spun out of No­var­tis, has raised $40 mil­lion in a Se­ries B round to speed its an­ti-ag­ing pro­gram through …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times